Breaking News Instant updates and real-time market news.

CVS

CVS Health

$75.54

2.34 (3.20%)

11:31
01/04/18
01/04
11:31
01/04/18
11:31

CVS: Level of margin compression in retail segment accelerating

  • 04

    Jan

  • 04

    Jan

CVS CVS Health
$75.54

2.34 (3.20%)

01/02/18
NEED
01/02/18
NO CHANGE
Target $88
NEED
Buy
CVS Health will have multiple 2018 catalysts, says Needham
Needham analyst Kevin Caliendo raised his price target on CVS Health (CVS) to $88 from $85 while keeping his Buy rating. Caliendo says he has been frustrated on the lack of movement in the stock following the Aetna (AET) merger announcement, attributing "investor apathy" to confusion over the management's guidance and lack of clarity around the tax reform impact. The analyst estimates that the company's corporate tax rate will move to about 26% from 39% and also models about $1 in net positive EPS accretion from the Aetna deal in 2019. Caliendo lists the company's S-4 filing in early January and the road show promoting the merger as key catalysts in the near term.
01/03/18
PIPR
01/03/18
UPGRADE
Target $207
PIPR
Overweight
Aetna upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James upgraded Aetna (AET) to Overweight and raised her price target for the shares to $207 from $187. The analyst sees a potential "win-win" scenario surrounding the outcome of the CVS Health (CVS) buyout. If the deal goes through James sees 15% share upside. If the deal does not go through, Aetna is set up for "strong operational performance" with stock appreciation potential of 15% by year end, the analyst contends.
01/04/18
RAJA
01/04/18
UPGRADE
RAJA
Strong Buy
CVS Health upgraded to Strong Buy from Outperform at Raymond James
01/04/18
RAJA
01/04/18
UPGRADE
Target $90
RAJA
Strong Buy
CVS Health upgraded to Strong Buy on Aetna deal, valuation at Raymond James
Raymond James analyst John Ransom upgraded CVS (CVS) to Strong Buy from Outperform and maintained a $90 price target. Ransom has increased conviction in the Aetna (AET) deal and believes the Street's implied probability of 40% likelihood of receiving regulatory approval is too low. Further, the analyst said CVS is poised for growth in 2018 given easier comps, an increase in Medicare Part D lives, and tax reform, and views valuation as attractive.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

08:13
11/20/18
11/20
08:13
11/20/18
08:13
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRM

Iron Mountain

$33.46

-0.38 (-1.12%)

08:11
11/20/18
11/20
08:11
11/20/18
08:11
Initiation
Iron Mountain initiated  »

Iron Mountain initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOWR

Tower International

$29.99

0.51 (1.73%)

08:11
11/20/18
11/20
08:11
11/20/18
08:11
Hot Stocks
Breaking Hot Stocks news story on Tower International »

Tower International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$16.51

-0.23 (-1.37%)

08:10
11/20/18
11/20
08:10
11/20/18
08:10
Hot Stocks
Clovis issued second U.S. patent covering rucaparib »

Clovis Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$14.50

-1.54 (-9.60%)

08:10
11/20/18
11/20
08:10
11/20/18
08:10
Conference/Events
Bloom Energy has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 05

    Dec

PME

Pingtan Marine Enterprise

$2.35

-0.05 (-2.08%)

08:09
11/20/18
11/20
08:09
11/20/18
08:09
Hot Stocks
Pingtan Marine Enterprise announces three new vessels sailed to sea »

Pingtan Marine Enterprise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRD

Nemaura Medical

$1.87

0.01 (0.54%)

08:09
11/20/18
11/20
08:09
11/20/18
08:09
Hot Stocks
Nemaura Medical signs exclusive license agreement with Al Danah Medical »

Nemaura Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EQBK

Equity Bancshares

$37.02

-0.7 (-1.86%)

08:08
11/20/18
11/20
08:08
11/20/18
08:08
Initiation
Equity Bancshares initiated  »

Equity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ESND

Essendant

$12.68

-0.02 (-0.16%)

08:08
11/20/18
11/20
08:08
11/20/18
08:08
Hot Stocks
Staples' affiliates extends expiration of tender offer for Essendant's shares »

Staples announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.84

-0.2 (-2.49%)

, BHGE

Baker Hughes

$23.00

-0.38 (-1.63%)

08:07
11/20/18
11/20
08:07
11/20/18
08:07
Recommendations
General Electric, Baker Hughes analyst commentary  »

GE 'fire sale'…

GE

General Electric

$7.84

-0.2 (-2.49%)

BHGE

Baker Hughes

$23.00

-0.38 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

HJLI

Hancock Jaffe Laboratories

$2.02

(0.00%)

08:07
11/20/18
11/20
08:07
11/20/18
08:07
Hot Stocks
Hancock Jaffe Laboratories receives update on VenoValve application from INVIMA »

Hancock Jaffe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MTEM

Molecular Templates

$4.59

-0.17 (-3.57%)

08:06
11/20/18
11/20
08:06
11/20/18
08:06
Initiation
Molecular Templates initiated  »

Molecular Templates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$85.55

-3.94 (-4.40%)

08:06
11/20/18
11/20
08:06
11/20/18
08:06
Earnings
Analog Devices sees Q1 adjusted EPS $1.28, plus or minus 7c, consensus $1.35 »

Sees Q1 revenue $1.51B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

KLIC

Kulicke & Soffa

$19.90

-0.96 (-4.60%)

08:05
11/20/18
11/20
08:05
11/20/18
08:05
Initiation
Kulicke & Soffa initiated  »

Kulicke & Soffa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

08:05
11/20/18
11/20
08:05
11/20/18
08:05
General news
U.S. equities are getting de-FAANGed again »

U.S. equities are getting…

08:05
11/20/18
11/20
08:05
11/20/18
08:05
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

BWA

BorgWarner

$39.40

-0.345 (-0.87%)

08:03
11/20/18
11/20
08:03
11/20/18
08:03
Conference/Events
BorgWarner management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ADI

Analog Devices

$85.55

-3.94 (-4.40%)

08:03
11/20/18
11/20
08:03
11/20/18
08:03
Earnings
Analog Devices reports Q4 adjusted EPS $1.55, consensus 1.52 »

Reports Q4 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

WOW

WideOpenWest

$10.02

-0.15 (-1.47%)

08:03
11/20/18
11/20
08:03
11/20/18
08:03
Conference/Events
WideOpenWest management to meet with JMP Securities »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

  • 03

    Dec

TOWR

Tower International

$29.99

0.51 (1.73%)

08:03
11/20/18
11/20
08:03
11/20/18
08:03
Hot Stocks
Tower International signs MOU to sell European operations »

Tower International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVFY

Nova Lifestyle

$0.87

-0.03 (-3.33%)

08:03
11/20/18
11/20
08:03
11/20/18
08:03
Hot Stocks
Nova Lifestyle receives over $1M in orders from Barsala »

Nova LifeStyle announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXTR

Extreme Networks

$6.20

-0.25 (-3.88%)

, HPE

HP Enterprise

$14.83

-0.37 (-2.43%)

08:02
11/20/18
11/20
08:02
11/20/18
08:02
Hot Stocks
Extreme Networks appoints Remi Thomas as CFO »

Extreme Networks (EXTR)…

EXTR

Extreme Networks

$6.20

-0.25 (-3.88%)

HPE

HP Enterprise

$14.83

-0.37 (-2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

TGT

Target

$77.13

-1.9 (-2.40%)

08:02
11/20/18
11/20
08:02
11/20/18
08:02
Recommendations
Target analyst commentary  »

Target sales solid, buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

CBRL

Cracker Barrel

$174.86

5.18 (3.05%)

08:00
11/20/18
11/20
08:00
11/20/18
08:00
Downgrade
Cracker Barrel rating change  »

Cracker Barrel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

MSFT

Microsoft

$104.62

-3.66 (-3.38%)

08:00
11/20/18
11/20
08:00
11/20/18
08:00
Options
Microsoft put buyer realizes 25% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.